BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Verkouteren BJA, Wakkee M, van Geel M, van Doorn R, Winnepenninckx VJ, Korpershoek E, Mooyaart AL, Reyners AKL, Terra JB, Aarts MJB, Reinders MGHC, Mosterd K. Molecular testing in metastatic basal cell carcinoma. J Am Acad Dermatol 2019:S0190-9622(19)33303-1. [PMID: 31870915 DOI: 10.1016/j.jaad.2019.12.026] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Zambrano-Román M, Padilla-Gutiérrez JR, Valle Y, Muñoz-Valle JF, Valdés-Alvarado E. Non-Melanoma Skin Cancer: A Genetic Update and Future Perspectives. Cancers (Basel) 2022;14:2371. [PMID: 35625975 DOI: 10.3390/cancers14102371] [Reference Citation Analysis]
2 Biezuner T, Brilon Y, Arye AB, Oron B, Kadam A, Danin A, Furer N, Minden MD, Hwan Kim DD, Shapira S, Arber N, Dick J, Thavendiranathan P, Moskovitz Y, Kaushansky N, Chapal-Ilani N, Shlush LI. An improved molecular inversion probe based targeted sequencing approach for low variant allele frequency. NAR Genom Bioinform 2022;4:lqab125. [PMID: 35156021 DOI: 10.1093/nargab/lqab125] [Reference Citation Analysis]
3 Kilgour JM, Jia JL, Sarin KY. Review of the Molecular Genetics of Basal Cell Carcinoma; Inherited Susceptibility, Somatic Mutations, and Targeted Therapeutics. Cancers (Basel) 2021;13:3870. [PMID: 34359772 DOI: 10.3390/cancers13153870] [Reference Citation Analysis]
4 Fania L, Didona D, Morese R, Campana I, Coco V, Di Pietro FR, Ricci F, Pallotta S, Candi E, Abeni D, Dellambra E. Basal Cell Carcinoma: From Pathophysiology to Novel Therapeutic Approaches. Biomedicines 2020;8:E449. [PMID: 33113965 DOI: 10.3390/biomedicines8110449] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
5 Bisceglia M, Panniello G, Galliani CA, Centola M, D'Errico MM, Minenna E, Tucci FA, Ben-Dor DJ. Metastatic Basal Cell Carcinoma of the Skin: A Comprehensive Literature Review, Including Advances in Molecular Therapeutics. Adv Anat Pathol 2020;27:331-53. [PMID: 32618586 DOI: 10.1097/PAP.0000000000000267] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
6 Li M, Wang H, Li W, Peng Y, Xu F, Shang J, Dong S, Bu L, Wang H, Wei W, Hu Q, Liu L, Zhao Q. Identification and validation of an immune prognostic signature in colorectal cancer. Int Immunopharmacol 2020;88:106868. [PMID: 32771948 DOI: 10.1016/j.intimp.2020.106868] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]